| For: | Chen JW, Liu CY, Li S, Wu SW, Cai C, Lu MQ. Sepsis-associated liver injury: Mechanisms and potential therapeutic targets. World J Gastroenterol 2024; 30(42): 4518-4522 [PMID: 39563749 DOI: 10.3748/wjg.v30.i42.4518] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i42/4518.htm |
| Number | Citing Articles |
| 1 |
Deqing Ruan, Xing Yan, Yanmei Tang, Shunhua Yang, Xinxin Yang, Mei Zhang, Shibo Yu, Jie Yu. The Endogenous Metabolite TDCA Ameliorates LPS-Driven Liver Injury via Modulation of Caspase-11/GSDMD-Mediated Pyroptosis. International Journal of Molecular Sciences 2026; 27(5) doi: 10.3390/ijms27052273
|
| 2 |
Lin Chai, Xiaoyu Liu, Ming Luo, Ling Li, Shubin Guo. E3 Ligase KPC1 promotes sepsis-induced liver injury via ubiquitination and processing of NF-κB1 p105 in kupffer cells. Tissue and Cell 2026; 103 doi: 10.1016/j.tice.2026.103649
|
| 3 |
Zexin Li, Liming Shang, Shaolei Wu, Cailu Chen, Zhidong Su, Shilai Li. 4-Octyl itaconate alleviates sepsis-induced liver injury by regulating ferroptosis via the OTUB1/TRAF3 axis. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-38612-6
|
| 4 |
Xiaona Yi, Tong Lin, Xingkai Shen, Bingyang Liu, Haiyan Mao, Meixia Zheng, Feifei Zhou, Yi Ding, Yuhong Jin. Adipose-derived Mesenchymal Stem Cells-Derived Exosomes Alleviate LPS-Induced Hepatocyte Injury in Sepsis by Inhibiting the JAK2/STAT3 Signaling Pathway. The Tohoku Journal of Experimental Medicine 2026; 269(1) doi: 10.1620/tjem.2025.J174
|
| 5 |
Zhen Yang, Xingyu Kao, Tianwei Zhu, Junna Lei, Na Huang, Jingli Chen, Mingfeng He, Qi Tang, Zhangrong Liang. Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1671732
|
| 6 |
Xinqi Xu, Tingyu Yang, Jiapan An, Bin Li, Zhimin Dou. Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1575554
|
| 7 |
Xiangli Kong, Bin Jiang, Cuiping Xu, Xiaohong Zhou, Feifei He. Prognostic value of the fibrosis-4 index for predicting in-hospital mortality in sepsis patients: evidence from MIMIC-IV and eICU databases. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-42522-y
|
| 8 |
Jianjun Wang, Yonghai Peng, Zhaohui Hu, Xi Chen, Sirui Chen, Pei Yang, Xintao Zeng, Decai Wang. Prognostic value of albumin-corrected anion gap in critically ill patients with sepsis-associated liver injury: a retrospective study. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-11321-7
|
| 9 |
Yupeng Li, Junyi Fan, Kamiar Alaei, Maryam Pishgar. Development of Machine Learning Models to Predict 28-Day Mortality in Patients with Sepsis-Associated Liver Injury. BioMedInformatics 2026; 6(1) doi: 10.3390/biomedinformatics6010004
|
| 10 |
文琦 李. The “Obesity Paradox” in Sepsis: Clinical Evidence, Underlying Mechanisms, and Research Challenges. Advances in Clinical Medicine 2026; 16(04) doi: 10.12677/acm.2026.1641575
|
| 11 |
Xiang Yunsheng, Yan Yumeng. Progress on the Protective Effect and the Mechanism of Chinese Medicine Injection and Chinese Medicine Monomeric Small Molecules on Sepsis‐Related Liver Injury. Gut Medicine 2026; 2(1) doi: 10.1002/gtm2.70011
|
| 12 |
Runze Jiang, Pingping Cai. Cell death in sepsis: unveiling new perspectives on organ dysfunction. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1823003
|
| 13 |
Binglin Song, Ping Liu, Chun Liu, Kangrui Fu, Xiangde Zheng, Ying Liu. Development and validation of a predictive model for continuous renal replacement therapy in sepsis patients using the MIMIC-IV database. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-07647-6
|
| 14 |
Yiqi Wu, Lu Wang, Zihui Deng, Yu Chen, Jiaqi Xu, Mingzheng Feng, Yongming Yao, Hongjun Kang. Human umbilical cord–derived mesenchymal stem cell exosomes ameliorate hepatocyte ferroptosis and sepsis-associated liver injury by restoring iron homeostasis in hepatocytes. Journal of Nanobiotechnology 2026; doi: 10.1186/s12951-026-04270-z
|
| 15 |
Yuhan Liu, Yu Lei, Luorui Shang, Zhaomin Yu, Li Wang, Jiabin Zhou, Guangtao Pan. Protective effects of Dachengqi Decoction in sepsis-associated liver injury based on network pharmacology analysis and experimental validation. Journal of Ethnopharmacology 2025; 353 doi: 10.1016/j.jep.2025.120450
|
| 16 |
Lirong Zheng, Tingting Jia, Yang Li, Zhihao Zhang, He Su, Ruifen Zhang. The interplay between gastrointestinal dysfunction and gut microbiota dynamics in sepsis. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1761536
|
| 17 |
Jing Yan, Yifeng Pan, Zhu Liu, Yulin Chen, Kai Hu, Yuanyuan Liu, Guangyao Wang, Liqun Li, Sheng Xie. Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway. Tissue and Cell 2026; 99 doi: 10.1016/j.tice.2025.103299
|
| 18 |
Chen Ouyang, Yuxi Liu, Xin Li, Pengpeng Liu, Quanyan Liu. Association between intravenous magnesium sulfate and mortality in patients with sepsis-associated liver injury: a retrospective cohort study. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1679032
|
| 19 |
Eleni V. Geladari, Anastasia-Amalia C. Kalergi, Apostolos A. Evangelopoulos, Vasileios A. Sevastianos. Sepsis and the Liver. Diseases 2025; 13(12) doi: 10.3390/diseases13120388
|
| 20 |
Kaina Zhang, Mengqing Liu, Yeqing Zheng, Zuozhong Gao, Ziwei Dong, Mengyao You, Yang Guo, Fanfan Liang, Zhenghang Zhao. TRIM16 mediates YAP1 K63-linked ubiquitination to alleviate sepsis-induced acute liver injury through YAP/Nrf2 axis in mice. Cell & Bioscience 2025; 16(1) doi: 10.1186/s13578-025-01517-4
|
| 21 |
Zhen Yang, Xingyu Kao, Lin Zhang, Na Huang, Yi Wang, Jingli Chen, Mingfeng He, Qi Tang, Zhangrong Liang. Dachaihu decoction alleviates septic liver injury by modulating the intestinal barrier dysfunction and suppressing the NF-κB/NLRP3/Caspase-1 signaling pathway. Chinese Medicine 2026; 21(1) doi: 10.1186/s13020-026-01420-1
|
| 22 |
Hilal Üstündağ, Songul Doganay. Septic Shock - From Pathophysiology to Patient Care. 2025; doi: 10.5772/intechopen.1009751
|
| 23 |
Yan Pan, Youting Xu, Ting Shui, Jiao Hong, Xuan Lu, Huilin Chen. Mesenchymal stem cell–derived small extracellular vesicles (sEVs) as a therapy for sepsis-related liver injury: evidence from a systematic review and meta-analysis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1707784
|